Trial
NCT00601861
Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Cancer
Intervention
recombinant interleukin-21
Why stopped
See termination reason in detailed description
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-01